Uptrend Under Pressure 93
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 93/100 · 7 distribution days (SPY) Sep 11 Full briefing →
View
Simple research view

BAX · Baxter International Inc.

$24.18 -0.86% Sep 10 close
Detected setup Three Weeks Tight · Setup Score 55/100

Stand aside — setup invalidated

Setup score 55, but price closes below stop $26.90 — stand aside until the condition resets.

Ask about BAX

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$BAX

Baxter International Inc.

Baxter International Inc. is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $13B.

Health Technology Medical Specialties stock Stage 2 · Advancing Base 1
$24.18 latest close
Historical record

No active setup in the latest scan — this page shows the last detection Legend AI made for $BAX. Every level, score and criterion below is computed from the Sep 10 close session (1 session old), and may no longer hold.

Historical verdict · setup score 55/100 · data Sep 10 close · 1 session old

Stand aside — setup invalidated

Setup score 55, but price closes below stop $26.90 — stand aside until the condition resets.

Earnings

Normal technical setup

No sourced report date Event risk is not modelled for this symbol

Deterministic evidence

BAX-0.86%
Sector proxy · XLV-0.55%
Broad market · SPY-0.60%
Same completed session window ending 2026-09-10. BAX was -0.31 points vs XLV. -0.26 points vs SPY.

Session internals Mixed

Rule: direction and internals disagree — it met neither the strong nor the weak rule. Judged on internals, not on the size of the move.

Vs prior close-0.86% From the open+0.12% Range position57% GapNo gap
QQQ confirmationConfirming (-1.06%) SMH confirmationConfirming (-2.44%)
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $24.18 -0.9% Sep 10 close
52W High $30.00 19.4% below high
Wks Since High 5w
Base Depth 20.3%
RS Rank 58 percentile of scan
SMA 50 $24.88
Avg Vol 6,243,701
Rel Vol (Sep 10) 0.92×
More stats
52W Low $15.73
Tight Wks 0
Base B1
SMA 200 $20.45
RS Line vs High -13.7%
RS Line Slope -9.4% ▼
Group Rank #25/58
ADR% 2.7%
ATR(14) $0.72 (3.0%)
Vol Pace (live) N/A
U/D Vol 0.78
A/D Days 19A / 11D
A/D Rating A+
VDU Bars 0/10 d
Position in 52-week range 59thpercentile of the 52-week range
$15.73low
$30.00high

BAX Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for BAX.

Create Free Account

Technical Analysis Report Card

$BAX · $24.18 · as of 2026-09-10 · multi-factor read
53
/ 100
Technicals 53/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▬ Sideways / consolidating
Monthly ▬ Sideways / consolidating

Moving Averages

50-day$24.88 ↓
100-day$21.91 ↑
200-day$20.45 ↑
Bullish (50 > 200)

RSI (14)

Reading37.6 · Bearish

Bearish momentum — sellers in control.

MACD (12/26/9)

StateBearish
Histogram-0.348

Bearish — MACD below its signal line and below zero. Histogram contracting.

Bollinger Bands (20,2)

%B / Width-8% · 11.5%
Squeeze — volatility compressing

Piercing the lower band — capitulation or strong selling. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.

Volume · Buyer vs Seller

Up/Down vol0.78 · Neutral
Rel volume0.92×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $30.0052-week high
Price · $24.18now
S · $21.28swing level
S · $19.38swing level
S · $18.58swing level

Fibonacci · Uptrend swing

23.6%$26.63
38.2%$24.55
50.0%$22.87
61.8%$21.18
78.6%$18.78

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for BAX — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Above 200-day MA50/200 bullish3.0:1 reward-to-risk
Want this read in a legend's voice? Ask a Legend about BAX
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 5 of 6 legends are Watching — building, not yet a confirmed buy.
Watch
Minervini B

Trend-template read: 9/12 pass; wait for the soft misses to improve.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $24.86, MA150 $20.74, MA200 $20.38
1.2 150-day MA > 200-day MAMA150 $20.74 vs MA200 $20.38
Failing evidence
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 66
2. ROE ≥ 17%ROE -16.6%
9/12 checks
Avoid
O'Neil D

CANSLIM read: fails L: RS rank ≥ 80 (IBD leadership).

Passing evidence
C: Quarterly EPS acceleration ≥ 25%+55.6% QoQ
S: Base tightness (ATR% ≤ 4.5%)ATR% 3.05%
Failing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 66
A: Annual earnings & revenue qualityRev +5.7% | ROE -16.6%
2/8 checks
Watch
Weinstein C

Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $24.86 vs MA200 $20.38
Failing evidence
Volume expansion above averageVolume ratio 0.94x
Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base
5/7 checks
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$24.86
Distance from 52-week high17.1% below high
Failing evidence
Relative strengthRS 66
Volume vs average0.94x
3/6 checks
Watch
Darvas B

Box-theory read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$24.86
Distance from 52-week high17.1% below high
Failing evidence
Relative strengthRS 66
Volume vs average0.94x
3/6 checks
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$24.86
Distance from 52-week high17.1% below high
Failing evidence
Relative strengthRS 66
Volume vs average0.94x
3/6 checks
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Latest candle: Doji — Open and close nearly equal — indecision. After a strong move it can signal a pause or pending reversal; wait for confirmation.

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▼ Falling
87RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +7 A+
A: 21 D: 14 Net: +765 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 4/7 met
B 4/7 criteria
Separate score from the Minervini Trend Template (6/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ +56%
Revenue growth ≥20% YoY +6%
Gross margin ≥30% 31%
ROE ≥17% -17%
RS rating ≥80 (leadership) 66
Stage 2 uptrend (Weinstein) Stage 2
Within 25% of 52W high -19.4%

Method Playbook

Trade it like Darvas EXACT LEVELS · PRO
Darvas B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use the top of the active Darvas box near the high as the mechanical breakout boundary.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require price to clear the box top with volume confirmation; movement inside the box remains observation, not a trigger.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the active box support or the canonical structural stop that proves the breakout failed.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: As higher boxes form, raise the stop beneath the newest confirmed box floor; the stop moves up only.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit when price breaks the active box floor or decisively falls back through the breakout structure.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis (historical)

Three Weeks Tight ⚠ Negative earnings (CANSLIM C fail) ⚠ Not actionable yet
55 setup score
RS Score 66
Trend template 6/8
CANSLIM 57.7* (C)
4 tight wks max 1.46%/wk ✓ vol dry vol 0.72x +67% advance Base Structure Grade 59
Why This Setup?
Three Weeks Tight · schematic

4 tight weeks, max change 1.46%, prior advance 67.4%, vol dry-up yes (0.72x), quality 59 | Strong trend (7/8) | Good RS (66) | High-confidence pattern (95%) | Stage 2 | Readiness 64/100 (early) | CANSLIM 57.7 (C) | ⚠ Negative earnings (CANSLIM C fail); Not actionable yet

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

1/7 universals met
  • A relative-strength leader — not met RS rank 58 — laggard
  • Risk is defined — not met No stop — undefined risk
  • Asymmetric reward — partly met No target set
  • Clear of earnings — partly met Report date unknown
  • Not chasing (in range) — partly met Pivot distance unknown
  • Volume confirms — partly met 0.9× average — light
  • In a confirmed uptrend — met Stage 2 · Trend template 6/8
Why these seven? → The Universal Edge

Minervini Trend Template

6/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $24.18 vs SMA150 $20.80 / SMA200 $20.45
SMA 150 above SMA 200 SMA150 $20.80 vs SMA200 $20.45
SMA 200 trending up Slope +0.68 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $24.88
Price above SMA 50 $24.18 vs SMA50 $24.88
30%+ above 52-week low +53.7% from $15.73
Within 25% of 52-week high -19.4% from $30.00
RS score above 70 RS 66

Fundamentals

52W Range
59%
Mkt Cap SEC
12.5B
EPS QoQ
+56%
Rev YoY
+6%
ROE
-17%
Gross Margin
31%
D/E
1.55
EPS TTM
$-1.87
Float
517M

Company

Company profile
Baxter International Inc.
BAX · NYSE · Health Technology · Medical Specialties
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
C 57.7* CANSLIM * disqualified on C, M
C · Curr. EPS
40
A · Annual EPS
47
N · New Highs
40
S · Supply/Demand
70
L · Leader RS
66
I · Inst. Spons.
96
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
8/8
W. RS
85
W. Support
$15.73
W. Resist
$30.00
Weekly Structure

Scan History

Sep 08: 55 (Three Weeks Tight)Sep 08: 65 (Three Weeks Tight)Sep 09: 55 (Three Weeks Tight)55
Sep 09
Three Weeks Tight ✓ Gate
55
Sep 08
Three Weeks Tight ✓ Gate
65 -2.7%
Sep 08
Three Weeks Tight ✓ Gate
55 -2.7%

Get the full picture on BAX

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial